Biotech pubblico
[search 0]
Altro
Scarica l'app!
show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
Ogni mese
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Artwork

1
Pharma and BioTech Daily

Pharma and BioTech News

Unsubscribe
Unsubscribe
Ogni giorno
 
This podcast aims to bring you a daily summary of most relevant news in Pharma and BioTech world, fully automated and Generated by ChatGPT. If you're interested in similar podcast checkout www.owith.ai
  continue reading
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Artwork
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
  continue reading
 
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
  continue reading
 
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
  continue reading
 
Artwork

1
Biotech Career Coach

Carina Clingman

Unsubscribe
Unsubscribe
Ogni settimana
 
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our free Slack Community or access great free resources, visit www.collaboratorycareerhub.com
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
Artwork

1
Building Biotechs

Recruitomics Consulting

Unsubscribe
Unsubscribe
Ogni settimana
 
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Artwork

1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado

Unsubscribe
Unsubscribe
Ogni settimana+
 
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
  continue reading
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Artwork
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
  continue reading
 
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
  continue reading
 
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
  continue reading
 
Artwork

1
The Biotech Futurist

thebiotechfuturistpodcast

Unsubscribe
Unsubscribe
Ogni mese
 
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
  continue reading
 
Artwork

1
The Longevity Biotech Show

The Longevity Biotech Show

Unsubscribe
Unsubscribe
Ogni mese
 
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
  continue reading
 
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
  continue reading
 
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
  continue reading
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
  continue reading
 
Loading …
show series
 
How do new drug applications move forward to approval? Four experts discuss the partnership between the FDA, the drug developer, and the data needed to move a product forward. It is a surprising discussion that reveals the depth of the FDA process. Joined by Dr. Debra Webster, Dr. Julia Marre, Dr. Michael Matthews and Dr. Jonathan Helfgott.…
  continue reading
 
Episode Description: Erum and Karl welcome renowned environmentalist, Murali Muthuswamy. He is the founder and chairman of Jananom Private Limited, founder of Elive Biotherapeutics USA, and advisor to Natural Nutrition. Murali explains the urgent and complex challenges of sustainable development. He also talks about the intricate balance required t…
  continue reading
 
This week, we have a conversation about clinical trial design with Gen Li, the president and founder of Phesi, a global provider of patient-centric data analysis. Earlier this year, Phesi’s global analysis of all clinical trials conducted in 2023 revealed that more than a quarter (28%) of trials were cancelled during phase II – above the average at…
  continue reading
 
How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth? In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector. As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Thera…
  continue reading
 
Unlock the secrets to cost-efficient antibody therapeutics with Brian Kelley, Senior Vice President of Process Development at VIR Biotechnology. In this illuminating episode, industry expert Brian Kelley shares invaluable insights into driving down manufacturing costs while maintaining quality and accessibility. From optimizing batch sizes to maxim…
  continue reading
 
This week on BioTech Nation, we explore new efforts in treating cancer with Dr. Sean Bohen, President and CEO of Olema Oncology. We discuss progress in treating breast cancer, particularly ER+/HER2- breast cancer, which accounts for 70% of diagnoses this year. They examine the biology behind these cancers and how Olema's lead compound, palbociclib,…
  continue reading
 
This week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast. We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every st…
  continue reading
 
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 1 of 3. My guest for this week’s episode is Bryan Dechairo, President, CEO, and Director at Sherlock Biosciences, an innovative biotech compan…
  continue reading
 
Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital even as he builds Tome Biosciences, where he serves as Pre…
  continue reading
 
This week my monthly BioSpace Career Coach column dropped, so I'm going into greater detail about each of the questions I answered in that column. We chat about excelling in Zoom calls, acing HR interviews, and navigating potential layoffs. This advice is widely applicable for those of you wanting to stand out and take control of your career. Check…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA recently approved a biosimilar of Stelara from Alvotech and Teva, set to launch early next year. Johnson & Johnson reported mixed sales performance for new multiple myeloma drugs, with Tecvayli sales exceeding expe…
  continue reading
 
Ivan Godinez Director of Product Management at Proteintech (2:00) What does Ivan do for Proteintech? (4:10) Importance of single-cell level resolution and getting diverse data to answer scientific questions with different approaches (6:10) How did Ivan get to where he wanted? (8:12) Ivan's entrance into biotech, and subsequently, product management…
  continue reading
 
This week we sat down with Kyriakos Economides, PhD, VP of Translational Pharmacology at Werewolf Therapeutics. If there’s one constant in biotech, it’s change. We discussed the evolution of a career, rolling with the punches, and the importance of a solid clinical plan early in the drug development lifecycle. Werewolf Therapeutics Inc. Linked In w…
  continue reading
 
Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominent figure in the biotech industry who co-founded Structure Therapeutics. Ray's extensive experience and pivotal role in advancing structure-based drug discovery make him a compelling guest for biotech e…
  continue reading
 
This week, we had a conversation with Catharine Smith - the Executive Director at the Termeer Foundation. Catharine is passionate about supporting biotech founders in growing patient-centric companies. We are thrilled about the Termeer Foundation and have been delighted to witness the Termeer Fellows thrive through the support, training, and commun…
  continue reading
 
Join us in this enlightening episode as we explore process economics with industry expert Brian Kelley. He is the Senior Vice President of Process Development at VIR Biotechnology. Unraveling the mysteries of cost management in antibody therapeutics, Brian sheds light on the intricate challenges faced by biotech scientists and engineers. Key Highli…
  continue reading
 
We live in amazing times of technological advance, but how are the real benefits of new tech lost to an inflated sense of risk? Dr. Felicia Wu from Michigan State University shares her expertise in describing the psychological basis of risk and applying it to questions like glyphosate and aspartame.Di Colabra
  continue reading
 
Episode Description: Today’s interview is with Joe Landolina, the CEO and Co-founder of Cresilon, Inc. Karl, Erum, and Joe discuss the untapped potential of animal health markets and innovative cancer treatments. Joe shares his entrepreneurial journey from founding Cresilon, Inc. in his NYU dorm to developing Vetigel, a revolutionary product design…
  continue reading
 
RTW is a global multi-strategy investment firm focused on supporting innovative biotech and biopharma companies across the US, Europe, and China. The company invests in both public and private companies across their entire life cycle, with a focus on those addressing next-generation gene and RNA therapies, rare diseases, targeted oncological, cardi…
  continue reading
 
Dive into the future of food with our latest episode, "From Lab to Table: The Science Behind Cultivated Meat." With our guest, Petra Hanga, a Lecturer in Biochemical Engineering at University College London and Chief Scientific Officer of Quest Meat Ltd., we unravel the secrets behind this groundbreaking technology. Key highlights: 1. Discover how …
  continue reading
 
This week - Dr. Sanjay Shukla, CEO of Atyr Pharma, discusses the revolutionary potential of mRNA technology in creating new medicines. They explore Atyr's pioneering approach to leveraging tRNA fragments for treating pulmonary sarcoidosis and other organ-specific conditions, aiming to improve patient outcomes while minimizing reliance on convention…
  continue reading
 
In this episode, we chatted with Isaac Stoner, M.B.A., the CEO of Octagon Therapeutics. Isaac is known for his expertise in building small companies and embarking on adventurous missions such as recovering airplane black boxes (yes, you read that correctly!). He also hosts a science enthusiast networking group in Cambridge, where attendees drink be…
  continue reading
 
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 3 of 3. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generatio…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentScientists have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug, which targets specific genetic mutations, has been successful in s…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA new study published in the Journal of Oncology has revealed a groundbreaking discovery in cancer treatment. Researchers have found a novel combination of drugs that have shown signific…
  continue reading
 
Dive into the fascinating world of cultivated meat with our guest, Petra Hanga, Lecturer in Biochemical Engineering – Cellular Agriculture at University College London and the Chief Scientific Officer of Quest Meat Ltd. In this episode, Petra sheds light on the intricacies of developing cultivated meat and reveals the key hurdles biotech scientists…
  continue reading
 
This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical Officer at ImmunityBio, gives us a long look behind th…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination therapy that has shown promising results in treating aggressive forms of can…
  continue reading
 
Episode Description: Elizabeth Reynolds, Managing Director of Starburst Aerospace’s US business, takes us into the fascinating intersection of space exploration and biotechnology, discussing how advancements in space can propel innovations on Earth. Elizabeth explains the challenges of sustaining human life during long-duration space missions and t…
  continue reading
 
In this episode, Dimple Doshi, MS, SAPM, shares her inspiring journey from a bench scientist to R&D Strategy and Operations, where she now blends science and business. As a first-generation immigrant, she navigated challenges and leveraged transferable skills to carve her unique career path. From the Northeastern Co-op program to her experience in …
  continue reading
 
Doloromics is a precision neuropharmaceuticals company. It was set up four years ago, to use newer technologies, particularly in the omics space, to take advantage of different single-cell transcriptomic technologies or proteomic technologies to better understand the progression of neurological diseases like chronic pain. The Doloromics pipeline is…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private biotech funding is on the rise, with venture firms investing in cell therapy developments in cancer care. Century has acquired Clade Therapeutics and raised $60 million through a private placement led by Bain Capita…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is planning to bring an RSV shot to adults aged 18-59, while Boehringer Ingelheim is facing staff layoffs due to biosimilar challenges. Amylyx made a rare move by pulling an ALS drug from the market. On the regulat…
  continue reading
 
The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges. Today I'm joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field. Our discussion spans fro…
  continue reading
 
Does uncovering the secrets of glycan engineering feel like navigating a maze of molecular complexity? In this captivating continuation of our exploration into the world of glycan engineering, we delve deeper into groundbreaking innovations and the crucial role of analytics in ensuring consistent quality. Henning von Horsten, Professor of Industria…
  continue reading
 
This week, we are pleased to welcome to the Data in Biotech podcast Brendan McCorkle, CEO of SciNote, a cloud-based ELN (Electronic Lab Notebook) with lab inventory, compliance, and team management tools. In this episode, we discuss how the priorities of ‘Research’ and ‘Development’ differ when it comes to the data they expect and how they use it, …
  continue reading
 
Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the po…
  continue reading
 
Part 2 of 3. As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. My guest for this week’s episode is Terry Lo, President and CEO of Vizgen. Vizgen is developing and commercializing the next generatio…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer ResearchScientists have made a significant breakthrough in cancer research, discovering a new potential treatment that targets specific cancer cells without harming healthy cells. This discovery…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in the Journal of Oncology reported a groundbreaking new treatment for certain types of cancer. The treatment, which involves a combination of immunotherapy and …
  continue reading
 
Does unlocking the secrets of glycan engineering seem like navigating a labyrinth of molecular complexity? In this episode, we delve into the pivotal role of glycans as critical quality attributes (CQAs) in biotherapeutics. Henning von Horsten, Professor of Industrial Bioengineering at HTW Berlin (University of Applied Sciences in Berlin), sheds li…
  continue reading
 
Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with the Flagship Pioneering-backed Ampersand, he's putting al…
  continue reading
 
This is an update on the American Chestnut Restoration Project, as discussed previously on the podcast. The American Chestnut dominated the forests of Appalachia until an imported fungus destroyed the entire range. Efforts to restore the chestnut and its ecology have employed a biotechnology approach, integrating a gene from wheat that limits the m…
  continue reading
 
Loading …

Guida rapida